Vincerx Pharma, Inc.

OTCPK:VINC Stock Report

Market Cap: US$258.0k

Vincerx Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of VINC?
Owner TypeNumber of SharesOwnership Percentage
Institutions220,6304.22%
Hedge Funds274,9085.25%
Individual Insiders293,7975.61%
General Public4,444,94284.9%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 254.5%.

Top Shareholders

Top 25 shareholders own 15.08% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
5.25%
Armistice Capital LLC
274,908US$13.6k870%no data
1.64%
Ahmed Hamdy
85,712US$4.2k0%no data
1.63%
Raquel Izumi
85,220US$4.2k1,880%no data
1.63%
Sage Rhino Capital, LLC
85,170US$4.2k0%no data
1.55%
John Byrd
80,910US$4.0k0%no data
0.82%
Citadel Advisors LLC
42,777US$2.1k0%no data
0.63%
Tom Thomas
32,838US$1.6k186%no data
0.6%
Goldman Sachs Group, Investment Banking and Securities Investments
31,567US$1.6k-0.01%no data
0.37%
Geode Capital Management, LLC
19,285US$950.859.7%no data
0.27%
The Vanguard Group, Inc.
14,317US$705.8-0.01%no data
0.21%
Two Sigma Securities, LLC, Asset Management Arm
11,053US$544.90%no data
0.21%
Millennium Management LLC
10,798US$532.30%no data
0.059%
Brian Druker
3,073US$151.512.2%no data
0.057%
Tower Research Capital Europe Limited
2,997US$147.80%no data
0.045%
BlackRock, Inc.
2,352US$115.9-0.08%no data
0.041%
Kevin Haas
2,139US$105.50%no data
0.036%
Alexander Seelenberger
1,907US$94.00%no data
0.025%
Laura Bushnell
1,293US$63.734.7%no data
0.0071%
John Lee
372US$18.3830%no data
0.0064%
Francisco Salva
333US$16.40%no data
0.0027%
UBS Asset Management AG
142US$7.0-96.9%no data
0.0019%
Morgan Stanley, Investment Banking and Brokerage Investments
102US$5.0-1.92%no data
0.00096%
SBI Holdings Inc., Asset Management Arm
50US$2.50%no data
0.00029%
Bank of America Corporation, Asset Management Arm
15US$0.736.4%no data
0.00008%
Guggenheim Partners, LLC
4US$0.20%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/28 06:21
End of Day Share Price 2025/05/28 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Vincerx Pharma, Inc. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kalpit PatelB. Riley Securities, Inc.
I-Eh JenLaidlaw & Company (UK) Ltd